DePuy Metal-on-Metal Hip Recall Issued Outside U.S. Due to Failure Rate

Problems involving high failure rates with yet another DePuy metal-on-metal hip replacement have caused Johnson & Johnson to issue a recall for more than 7,500 implants sold outside the United States, coming more than two years after the manufacturer issued a DePuy ASR metal-on-metal hip recall following similar issues that surfaced in August 2010. 

According to information sent to Germany’s Federal Institute for Drugs and Medical Devices, Johnson & Johnson’s DePuy Orthopaedics subsidiary disclosed last month that it was issuing a recall for the DePuy Adept implant, warning doctors that the modular heads of the artificial hip system should not be used.

The DePuy Adept hip recall was issued after an analysis of data from a British hip implant registry indicated the implant failure rate was about 12% within seven years.

Learn More About

Hip Replacements Lawsuits

Lawsuits are being reviewed for several different dangerous and defective hip replacement systems.

Learn More See If You Qualify For Compensation

The recalled DePuy Adept hip implants were sold in at least 21 countries worldwide, but not the United States. The hip implants were on the market from 2004 through September 2011.

DePuy ASR Hip Recall Lawsuits in U.S.

The decision to remove the DePuy hip implant from the market comes as manufacturer faces thousands of lawsuits over the recalled DePuy ASR hip, which is another metal-on-metal implant that was removed from the market amid reports of higher-than-expected failure rates associated with debris that may be shed into the body as the metal parts rub against each other over time.

Johnson & Johnson announced the DePuy ASR metal hip recall in August 2010, again pointed to British hip implant registry data that found a 12 to 13% failure rate associated with the device.

The first DePuy ASR trial is currently underway in California state court, with a number of former Johnson & Johnson employees and other witnesses providing testimony that suggests the manufacturer knew about the risk of problems with metal-on-metal hips long before they issued the ASR recall. Some internal documents offered during the trial have suggested that the company’s own predictions estimated a failure rate may reach as high as 37%.

The DePuy Adept hip resurfacing and total hip system also features a metal-on-metal design, with a metal ball at the top of the thigh bone that fits within a metal hip socket. The recall only impacts the ball portion of the implant.

Metal-on-Metal Hip Problems Not Limited to ASR and Adept

In addition to lawsuits over the DePuy ASR, other metal-on-metal hip designs have been the focus on large numbers of complaints, including the DePuy Pinnacle hip, Biomet M2A Magnum hip and Wright Medical Conserve Cup.

In January, the FDA released new guidance for metal-on-metal hip replacements. The agency told doctors that metal-on-metal hip replacement systems should only be used if other artificial hip implants were not appropriate, and called on manufacturers to prove that their implants were safe enough to stay on the market. Future metal-on-metal hip designs will have to undergo extensive human clinical trials before being made available for sale, the FDA decreed.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades
Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades (Posted today)

After decades of medical research and reported Depo-Provera side effects, Pfizer should have known that its birth control shot increases the risks of meningioma brain tumors, yet failed to warn women or the medical community.

Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto
Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto (Posted today)

Bayer and Monsanto prevailed in a Roundup lawsuit that went to trial in Philadelphia this week, after a jury found that exposure to the herbicide did not cause a man to develop non-Hodgkin's lymphoma.

Family Seeks Remand of Bard Hernia Mesh Wrongful Death Lawsuit, After Global Settlement Negotiations “Have Dragged”
Family Seeks Remand of Bard Hernia Mesh Wrongful Death Lawsuit, After Global Settlement Negotiations “Have Dragged” (Posted yesterday)

The Bard hernia mesh lawsuit has been pending for years in the federal MDL, where family indicates global settlement negotiations have stalled, leading to a request to allow their claim to be remanded for trial.